Back to Top Therapy for AL Amyloidosis: Advancements and Innovations for 2022
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Therapy for AL Amyloidosis 2022

key information

source: Amyloidosis Support Groups

year: 2022

authors: Jeffrey Zonder

summary/abstract:

Antibodies (Plasma Cells) Therapy for AL Amyloidosis 2022 lists different medications and therapies for treating AL amyloidosis, a blood disorder characterized by abnormal deposits of a protein called immunoglobulin light chain in various organs and tissues of the body. The table is divided into several categories: Alkylating Agents, Proteasome Inhibitors, Steroids, IMiDs, Fibril-Directed Agents, and Light Chain Stabilizers. Some of the therapies listed in the table have FDA approval. The FDA-approved medication for AL Amyloidosis is Dara-CyBorD, a combination of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone.

 

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close